Guided Therapeutics (GTHP) Cash from Operations (2016 - 2025)

Guided Therapeutics recorded quarterly Cash from Operations of 291000.0 in Q4 2025, down 5.05% quarter-over-quarter from 277000.0 in Q3 2025, and up 12.35% year-over-year from 259013.4 in Q4 2024.

Guided Therapeutics' Cash from Operations history runs 10 years deep, the most recent figure standing at 291000.0 for Q4 2025.

  • In Q4 2025, Cash from Operations rose 12.35% year-over-year to 291000.0; the TTM figure through Dec 2025 stood at 1068000.0 (up 4.56% YoY), while the FY2025 annual figure was 1068000.0, up 4.56% from the prior year.
  • Cash from Operations came in at 291000.0 for Q4 2025 at Guided Therapeutics, down from 277000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 159000.0 in Q4 2021 to a low of 739000.0 in Q3 2021.
  • A 5-year average of 350200.0 and a median of 334000.0 in 2023 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations soared 148.04% in 2021 and plunged 313.21% in 2022, its largest moves.
  • Guided Therapeutics' Cash from Operations stood at 159000.0 in 2021, then sank by 313.21% to 339000.0 in 2022, then climbed by 0.88% to 336000.0 in 2023, then grew by 1.19% to 332000.0 in 2024, then increased by 12.35% to 291000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods registered 291000.0, 277000.0, and 169000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.32 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 581.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.74 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 348.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 43.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 220.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 525.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 290.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 335.40 Mn
10 Guided Therapeutics - - 458,000.00 -291,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -291,000.00
Dec 31, 2025 -291,000.00
Sep 30, 2025 -277,000.00
Sep 30, 2025 -277,000.00
Jun 30, 2025 -169,000.00
Jun 30, 2025 -169,000.00
Mar 31, 2025 -331,000.00
Mar 31, 2025 -331,000.00
Dec 31, 2024 -332,000.00
Dec 31, 2024 -332,000.00
Sep 30, 2024 -473,000.00
Sep 30, 2024 -473,000.00
Jun 30, 2024 -214,000.00
Jun 30, 2024 -214,000.00
Mar 31, 2024 -100,000.00
Mar 31, 2024 -100,000.00
Dec 31, 2023 -336,000.00
Dec 31, 2023 -336,000.00
Sep 30, 2023 -473,000.00
Sep 30, 2023 -473,000.00
Jun 30, 2023 -438,000.00
Jun 30, 2023 -438,000.00
Mar 31, 2023 -499,000.00
Mar 31, 2023 -499,000.00
Dec 31, 2022 -339,000.00
Dec 31, 2022 -339,000.00
Sep 30, 2022 -612,000.00
Sep 30, 2022 -612,000.00
Jun 30, 2022 -349,000.00
Jun 30, 2022 -349,000.00
Mar 31, 2022 -179,000.00
Mar 31, 2022 -179,000.00
Dec 31, 2021 159,000.00
Dec 31, 2021 159,000.00
Sep 30, 2021 -739,000.00
Sep 30, 2021 -739,000.00
Jun 30, 2021 -692,000.00
Jun 30, 2021 -692,000.00
Mar 31, 2021 -320,000.00
Mar 31, 2021 -320,000.00
Dec 31, 2020 -331,000.00
Dec 31, 2020 -331,000.00
Sep 30, 2020 -606,000.00
Sep 30, 2020 -606,000.00
Jun 30, 2020 -408,000.00
Jun 30, 2020 -408,000.00
Mar 31, 2020 -530,000.00
Mar 31, 2020 -530,000.00
Dec 31, 2019 -204,000.00
Dec 31, 2019 -204,000.00
Sep 30, 2019 -228,000.00
Sep 30, 2019 -228,000.00
Jun 30, 2019 -188,000.00
Jun 30, 2019 -188,000.00
Mar 31, 2019 -186,000.00
Mar 31, 2019 -186,000.00
Dec 31, 2018 -311,000.00
Dec 31, 2018 -311,000.00
Sep 30, 2018 -417,000.00
Sep 30, 2018 -417,000.00
Jun 30, 2018 -242,000.00
Jun 30, 2018 -242,000.00
Mar 31, 2018 -395,000.00
Mar 31, 2018 -395,000.00
Dec 31, 2017 -663,000.00
Dec 31, 2017 -663,000.00
Sep 30, 2017 -204,000.00
Sep 30, 2017 -204,000.00
Jun 30, 2017 130,000.00
Jun 30, 2017 130,000.00
Mar 31, 2017 -407,000.00
Mar 31, 2017 -407,000.00
Dec 31, 2016 -197,000.00
Dec 31, 2016 -197,000.00